Inventor
Young Kee Shin
Inventor
Seoul, KR
Overview
Patents· 14 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
A61KPreparations for medical, dental or toiletry purposes13%
C07KPeptides13%
C12NMicroorganisms or enzymes13%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms13%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology8%
C40BCombinatorial chemistry5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
B82BNanostructures formed by manipulation of individual atoms, molecules, or limited collections of atoms or molecules as discrete units3%
C01GCompounds containing metals not covered by subclasses c01d or c01f3%
PatentTitleYear
10,806,799Human interferon-beta variant conjugated immunocytokine and method for preparing same202010,718,030Methods for predicting effectiveness of chemotherapy for a breast cancer patient202010,655,187Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof202010,576,158Immune conjugate having dendron conjugated to antibody and use thereof202010,428,386Gene for predicting the prognosis for early-stage breast cancer, and a method for predicting the prognosis for early-stage breast cancer by using the same201910,304,561Data processing, analysis method of gene expression data to identify endogenous reference genes201910,221,418Composition for treating cancer associated with HPV infection20199,751,941'Antigen derived from extracellular domain of multi-transmembrane protein and uses thereof'20179,719,093'Composition for treating cancer associated with HPV infection'20179,639,660'Data processing, analysis method of gene expression data to identify endogenous reference genes'20179,123,916'Rechargeable battery'20158,425,906'Method to inhibit cancer targeting CD24'20138,377,899'Composition for treatment of cervix cancer'20138,101,716'Human interferon-beta mutein'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2013Patents assigned to SHIN YOUNG KEE (3)· patent assignee history
2012Patents assigned to AHN JI SOO (1)· patent assignee history
2012–2020Based in Seoul, KR· patent location history
2013–2017Patents assigned to SNU R&DB FOUNDATION (3)· patent assignee history
2015Based in Yongin-si, KR· patent location history
2017–2020Patents assigned to GENCURIX INC (5)· patent assignee history
2017–2020Patents assigned to ABION INC (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENCURIX INC | 5 | 2017–2020 |
| ABION INC | 4 | 2017–2020 |
| SHIN YOUNG KEEself | 3 | 2012–2013 |
| SNU R&DB FOUNDATION | 3 | 2013–2017 |
| AHN JI SOO | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Seoul, KR | 13 | 2012–2020 |
| Yongin-si, KR | 1 | 2015 |